Aperio Group, LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$600,000
+84.6%
45,669
+35.7%
0.00%
+100.0%
Q3 2020$325,000
-14.0%
33,662
+1.9%
0.00%0.0%
Q2 2020$378,000
+48.2%
33,021
+34.1%
0.00%0.0%
Q1 2020$255,000
-9.9%
24,629
+43.0%
0.00%0.0%
Q4 2019$283,000
+72.6%
17,224
+39.8%
0.00%0.0%
Q3 2019$164,000
+20.6%
12,320
+27.4%
0.00%0.0%
Q2 2019$136,000
-29.5%
9,671
-7.6%
0.00%0.0%
Q1 2019$193,000
-35.5%
10,471
-8.5%
0.00%
-50.0%
Q4 2018$299,00011,4420.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders